Cormorant Asset Management, LP - Insider Trading & Ownership

Entity
Company
Location
200 Clarendon Street, 52 Nd Floor, Boston, Massachusetts
Summary
The estimated value of insider holdings of Cormorant Asset Management, LP is at least $1.08 B dollars as of May 8, 2024. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $642 M. Cormorant Asset Management, LP is the 10%+ Owner of Ambrx Biopharma, Inc. and owns shares of Ambrx Biopharma, Inc. (AMAM) stock worth about $110 M. Cormorant Asset Management, LP is the 10%+ Owner of EyePoint Pharmaceuticals, Inc. and owns shares of EyePoint Pharmaceuticals, Inc. (EYPT) stock worth about $103 M. Cormorant Asset Management, LP is the 10%+ Owner of Corbus Pharmaceuticals Holdings, Inc. and owns shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock worth about $87.6 M. Cormorant Asset Management, LP is the Former 10% Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $60.8 M. Cormorant Asset Management, LP is the Former 10% Owner of Aerovate Therapeutics, Inc. and owns shares of Aerovate Therapeutics, Inc. (AVTE) stock worth about $39.6 M. Cormorant Asset Management, LP is the Former 10% Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $9.84 M. Cormorant Asset Management, LP is the 10%+ Owner of Immuneering Corp and owns shares of Immuneering Corp (IMRX) stock worth about $8.6 M. Cormorant Asset Management, LP is the Former 10% Owner of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $7.04 M. Cormorant Asset Management, LP is the Former 10% Owner of Icosavax, Inc. and owns shares of Icosavax, Inc. (ICVX) stock worth about $6.68 M. Cormorant Asset Management, LP is the Former 10% Owner of Ventyx Biosciences, Inc. and owns shares of Ventyx Biosciences, Inc. (VTYX) stock worth about $2.99 M. Cormorant Asset Management, LP is the Former 10% Owner of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $2.31 M. Cormorant Asset Management, LP is the Former 10% Owner of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $1.57 M. Cormorant Asset Management, LP is the Former 10% Owner of Elevation Oncology, Inc. and owns shares of Elevation Oncology, Inc. (ELEV) stock worth about $1.14 M.
All Insider Reports
All Insider Reports

Ownership of Cormorant Asset Management, LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMAM Ambrx Biopharma Cayman, Inc. 10%+ Owner $642 M +$19.6 M +3.15% Sep 15, 2023
AMAM Ambrx Biopharma, Inc. 10%+ Owner $110 M +$9.14 M +9.04% Oct 23, 2023
EYPT EyePoint Pharmaceuticals, Inc. 10%+ Owner $103 M +$89.5 M +668% May 6, 2024
CRBP Corbus Pharmaceuticals Holdings, Inc. 10%+ Owner $87.6 M +$13.1 M +17.6% Mar 7, 2024
GLUE Monte Rosa Therapeutics, Inc. Former 10% Owner $60.8 M Jun 28, 2021
AVTE Aerovate Therapeutics, Inc. Former 10% Owner $39.6 M Jul 2, 2021
VERV Verve Therapeutics, Inc. Former 10% Owner $9.84 M Jun 21, 2021
IMRX Immuneering Corp 10%+ Owner $8.6 M -$2.75 M -24.3% Apr 1, 2024
TYRA Tyra Biosciences, Inc. Former 10% Owner $7.04 M Sep 17, 2021
ICVX Icosavax, Inc. Former 10% Owner $6.68 M Aug 2, 2021
VTYX Ventyx Biosciences, Inc. Former 10% Owner $2.99 M Oct 25, 2021
VIGL Vigil Neuroscience, Inc. Former 10% Owner $2.31 M Jan 11, 2022
PYXS Pyxis Oncology, Inc. Former 10% Owner $1.57 M Oct 13, 2021
ELEV Elevation Oncology, Inc. Former 10% Owner $1.14 M Jun 29, 2021
GRNA GreenLight Biosciences Holdings, PBC Other* Jul 20, 2023

Insider Transactions Reported by Cormorant Asset Management, LP:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership